ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,566.46
1.12%
US Tech 100
19,255.20
1.29%
Dow Jones
40,415.44
0.32%
Brent Oil
81.785
0.33%
Bitcoin
67,477.93
-0.19%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bio Path Holdings Inc (BPTH)

  7. Bio Path Holdings Inc (BPTH) News

BPTH

Bio Path (BPTH)

Bio Path Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPTH
DateTimeSourceHeadlineSymbolCompany
07/11/20248:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
07/08/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Provides Clinical Update and Expansion PlansNASDAQ:BPTHBio Path Holdings Inc
06/17/20248:00AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BPTHBio Path Holdings Inc
06/17/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BPTHBio Path Holdings Inc
06/14/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
06/14/20247:18AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
06/14/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
06/11/20245:30PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
06/05/20245:46PMGlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
06/05/20245:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
06/04/20248:00AMGlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
06/03/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
06/03/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
05/30/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
05/24/20247:00AMGlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
05/23/20245:00PMGlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:50AMIH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
05/15/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
05/14/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
05/08/20247:00AMGlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
04/19/202412:14PMGlobeNewswire Inc.Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
04/18/20241:57PMGlobeNewswire Inc.Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
04/18/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) PatientsNASDAQ:BPTHBio Path Holdings Inc
04/15/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
04/02/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Provides 2024 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
03/11/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
03/08/20245:11PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
03/08/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
03/08/20247:00AMGlobeNewswire Inc.Bio-Path Holdings Reports Full Year 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:BPTH

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
HIRU
Hiru (PK)
USOTC
CRTG
Coretec (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved